Skip to content

A randomized, double-blind, crossover taste testing study in healthy subjects comparing JZP-258 and placebo.

A randomized, double-blind, crossover taste testing study in healthy subjects comparing JZP-258 and placebo. - JZP-258 Taste testing study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46727
Enrollment
56
Registered
2018-03-06
Start date
2018-03-29
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Narcolepsy sleeping disorder

Interventions

Not applicable.

Sponsors

Jazz Pharmaceuticals
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: healthy male or female 18 - 50 years of age (BMI) 18.0 - 35.0 kilograms/meter2 non-smoking

Exclusion criteria

Exclusion criteria: Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.

Design outcomes

Primary

MeasureTime frame
De mogelijkheid om onderscheid te maken tussen JZP-258 en placebo voor beide replicaten.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)